Coverage Update: SI-BONE iFuse Implants

SI-BONE announced that Blue Cross Blue Shield Association (BCBSA) Evidence Street’s annual technology evidence review states that iFuse Transiliac Triangular Implants are the only implants for the treatment of sacroiliac joint pain with evidence sufficient to determine a meaningful improvement in the net health outcome. BCBSA has determined that...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us